trending Market Intelligence /marketintelligence/en/news-insights/trending/-aDvpzK50ceMDk4DMjDeGg2 content esgSubNav
In This List

Odonate Therapeutics appoints director

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Odonate Therapeutics appoints director

Odonate Therapeutics Inc. appointed Laura Douglass to its board, effective Dec. 3.

Douglass is the president and CEO of Next Generation Clinical Research Consulting Inc., a contract research organization in the pharmaceutical industry.

Odonate Therapeutics is a pharmaceutical company developing treatments for cancer.